Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Vertex Pharmaceuticals VRTX Stock Holding History

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$844K	Sell	1,700 -400	-19%	-$177K	0.34%	80
2026 Q1	$938K	Hold	2,100	–	–	0.48%	66
2025 Q4	$952K	Hold	2,100	–	–	0.46%	65
2025 Q3	$822K	Buy	2,100 +900	+75%	+$376K	0.44%	65
2025 Q2	$534K	Hold	1,200	–	–	0.28%	77
2025 Q1	$582K	Hold	1,200	–	–	0.37%	72
2024 Q4	$483K	Buy	+1,200	New	+$556K	0.28%	79

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s VRTX Position: Q2 2026 in Review

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) reduced its Vertex Pharmaceuticals (VRTX) stake by 19% in Q2 2026, selling an estimated $177K and leaving 1,700 shares worth $844K. The position accounts for 0.34% of the portfolio, ranked #80.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $952K in Q4 2025. 1,344 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) held 1,700 shares of Vertex Pharmaceuticals worth $844K as of Q2 2026.
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) sold 400 Vertex Pharmaceuticals shares in Q2 2026, an estimated $177K.
Vertex Pharmaceuticals made up 0.34% of Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s portfolio in Q2 2026, its #80 holding.
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s Vertex Pharmaceuticals position peaked at $952K in Q4 2025.
1,344 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s 13F filing for Q2 2026, filed 22 Jul 2026.